PBS struggles to adopt orphans

By Megan Brodie 4 years ago | In Products, Regulatory

6 May 2022 Only one in four drugs registered in Australia as an orphan in…

This is subscriber-only content. Please login to continue reading.

2 responses

Nicola Richards says:

6 May 2022 at 6:57 am

Great analysis to show the new registration pathways provide faster outcomes and the PBAC processes need to evolve to keep up for Australians. Well done to those that can bridge the gap and minimise the delays between registration and funding
Stefan Orange says:

6 May 2022 at 8:50 am

Excellent article. The clinical evidence and high clinical need for Australian patients is being well recognised by the TGA with accelerated approvals pathways. We need to work on the baton change to funding.

Comments are closed.